Research ArticleProceedings of the 2017 Viral Clearance Symposium
Proceedings of the 2017 Viral Clearance Symposium, Session 1.1: Upstream Mitigation, Part 1—Cell Bank and Bulk Harvest Testing
Glen Bolton and Dayue Chen
PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 455-460; DOI: https://doi.org/10.5731/pdajpst.2018.009092
Glen Bolton
1Amgen, 360 Binney Street, Cambridge, MA 02142, USA; and
Dayue Chen
2Eli Lilly, Bioprocess Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA

Reference
- 1.↵
- 2.↵
- Besselsen D.G.,
- et al
- 3.↵
- Berting A.,
- Farcet M.R.,
- Kreil T.R.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 72, Issue 5
September/October 2018
Proceedings of the 2017 Viral Clearance Symposium, Session 1.1: Upstream Mitigation, Part 1—Cell Bank and Bulk Harvest Testing
Glen Bolton, Dayue Chen
PDA Journal of Pharmaceutical Science and Technology Sep 2018, 72 (5) 455-460; DOI: 10.5731/pdajpst.2018.009092
Jump to section
- Article
- Abstract
- Session Background and Overview
- Participant Contributions
- An Innovative NGS Approach for the Specific Detection of Replicative Viruses in Cell Substrate
- Detection of Retrovirus in a Perfusion Bioreactor Process
- Use of a “Generic” RVLP Value in Determining the Retroviral Safety Margin
- Detection of MMV, or Not
- Conflict of Interest Declaration
- Reference
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.